On the recordMarch 4, 2013
A liability challenge. Generic drug makers defense faces a Supreme Court test.
Source
congress.govA liability challenge. Generic drug makers defense faces a Supreme Court test.
Goodlatte refers to a legal case involving generic drug makers and its implications.
Share
More from Bob Goodlatte
The fact of the matter is this Committee has jurisdiction over this narrower focus regarding protecting the Fourth Amendment.
I think the PATRIOT Act went off track in not defining some of the areas that set parameters around government gathering data.
I think there are a number of circumstances, particularly when civil rights, religious organizations, political campaigns, and other important things are being involved in surveillance, that there ought to be somebody not representing the…
I think that antitrust laws definitely should be utilized to promote competition.